F

FibroGen

FGEN

0.48000
USD
-0.052
(-9.77%)
مفتوح الان
حجم التداول
1,500
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
38,152,299
أصول ذات صلة
A
ALNY
31.19
(13.13%)
268.66 USD
A
ARWR
-1.160
(-4.06%)
27.410 USD
E
EXEL
0.740
(3.15%)
24.200 USD
I
IONS
1.830
(3.70%)
51.330 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
R
RARE
-0.870
(-1.93%)
44.140 USD
S
SRPT
1.650
(1.16%)
144.000 USD
VRTX
9.75
(1.97%)
505.40 USD
الأخبار المقالات

العنوان: FibroGen

القطاع: Healthcare
الصناعة: Biotechnology
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.